2004
DOI: 10.1016/j.jad.2004.04.002
|View full text |Cite
|
Sign up to set email alerts
|

The phenomenology and treatment of interferon-induced depression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

8
138
1
6

Year Published

2006
2006
2019
2019

Publication Types

Select...
9
1

Relationship

3
7

Authors

Journals

citations
Cited by 206 publications
(153 citation statements)
references
References 60 publications
8
138
1
6
Order By: Relevance
“…2). In particular, exogenous administration of IFN-a has been shown to cause depression in some patients (Musselman et al, 2001;Hauser et al, 2002;Loftis & Hauser, 2004). This IFN-induced depression has been attributed to the activation of the cytokine network (i.e., IFN-g) and IDO, resulting in perturbations of the serotonergic system (Menkes & MacDonald, 2000;Bonaccorso et al, 2002;Capuron et al, 2003;Turner & Blackwell, 2005).…”
Section: Factors Affecting 5-hydroxytryptophan Availability For Serotmentioning
confidence: 99%
“…2). In particular, exogenous administration of IFN-a has been shown to cause depression in some patients (Musselman et al, 2001;Hauser et al, 2002;Loftis & Hauser, 2004). This IFN-induced depression has been attributed to the activation of the cytokine network (i.e., IFN-g) and IDO, resulting in perturbations of the serotonergic system (Menkes & MacDonald, 2000;Bonaccorso et al, 2002;Capuron et al, 2003;Turner & Blackwell, 2005).…”
Section: Factors Affecting 5-hydroxytryptophan Availability For Serotmentioning
confidence: 99%
“…Increase symptoms of depression during IFN therapy has been explained by depletion of serotonin, decreases in tryptophan, and increases in tryptophan catabolism (18).…”
Section: Assessment Of Ha Scores As In Tablementioning
confidence: 99%
“…As interferon treatment has also been proven to reduce the risk of HCC [9][10][11], interferon treatment has been actively administered for chronic hepatitis C. However, interferon treatment has various adverse events that may prevent completion of the full treatment regimen. These include psychiatric adverse events, especially depression, which often leads to a discontinuation of interferon treatment [12][13][14][15][16][17][18] pegylated interferon-α-2b and ribavirin combination treatment has been reported to range from 29 to 36% [5][6][7]. To treat depression, antidepressants such as selective serotonin reuptake inhibitor (SSRI), serotonin noradrenaline reuptake inhibitor (SNRI), and sulpiride have been shown to be effective [19][20][21].…”
Section: Introductionmentioning
confidence: 99%